We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Bracco

Offers products, injectors and solutions portfolio for all diagnostic applications from constrast media to medical de... read more Featured Products: More products

Download Mobile App





Bracco Diagnostics Unveils Contrast Media and Device Offerings at RSNA 2019

By MedImaging International staff writers
Posted on 05 Dec 2019
Image: Multihance Contrast Media (Photo courtesy of Bracco Diagnostics Inc.)
Image: Multihance Contrast Media (Photo courtesy of Bracco Diagnostics Inc.)
Bracco Diagnostics Inc. (Monroe Township, N.J., USA), the US subsidiary of Bracco Imaging S.p.A., highlighted its full scope of offerings and advancements with its diagnostic imaging services and solutions portfolio at the 2019 RSNA Annual Meeting held December 1–6 in Chicago, USA.

Bracco Imaging develops, manufactures, and markets diagnostic imaging agents and solutions that meet medical needs. Bracco Imaging offers a product and solution portfolio for all key diagnostic imaging modalities, including X-ray Imaging (including Computed Tomography-CT, Interventional Radiology, and Cardiac Catheterization), Magnetic Resonance Imaging (MRI), Contrast Enhanced Ultrasound (CEUS), and Nuclear Medicine through radioactive tracers. The diagnostic imaging portfolio is completed by a range of medical devices and advanced administration systems for contrast imaging products.

At RSNA 2019, Bracco Diagnostics highlighted its focus on patient care and the power of choice, giving customers the ability to assess each patient's personal needs and decide upon the best contrast media option for their patients, whether the contrast is for an MRI, X-ray/CT, Ultrasound, or Nuclear Medicine examination. The company also stated its commitment towards smart solutions and innovative technologies to improve workflow, optimize image quality, and maximize efficiency. Bracco Diagnostics expressed its dedication and passion for funding education for the medical community with comprehensive, convenient programs tailored to address today's health care challenges. It offered interactive carousels for RSNA attendees to explore the company’s offerings and clinical breakthroughs to improve outcomes.

"We come to this year's RSNA eager to discuss the science of imaging with our customers and our industry partners," said Cosimo De Pinto, Vice President of Marketing at Bracco. "To say the next few years are going to be transformational would be an understatement. The balance of providing value-based care while riding the wave of technology and innovation can be daunting for our customers, but we believe we are in a unique position at Bracco to support both endeavors. It's an exciting time to be in the field of diagnostic imaging."

Related Links:
Bracco Diagnostics Inc.

Ultrasound Table
Women’s Ultrasound EA Table
Digital Radiographic System
OMNERA 300M
Adjustable Mobile Barrier
M-458
Ultrasound-Guided Biopsy & Visualization Tools
Endoscopic Ultrasound (EUS) Guided Devices

Channels

General/Advanced Imaging

view channel
CT and fused SPECT-CT images L to R of representative healthy control, pulmonary fibrosis participant & hypersensitivity pneumonitis participant (Image courtesy of SNMMI)

New SPECT/CT Method Differentiates Inflammation from Fibrosis in Interstitial Lung Disease

Interstitial lung disease (ILD) encompasses more than 200 disorders that inflame or scar the lung interstitium and can lead to progressive respiratory failure. Determining whether active inflammation is... Read more

Imaging IT

view channel
Image: Researchers develop a vision-language model trained on large-scale data to generate clinically relevant findings from chest computed tomography images through visual question answering (Ms. Maiko Nagao from Meijo University, Japan)

Interactive AI Tool Supports Explainable Lung Nodule Assessment

Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more

Industry News

view channel
Image: MIM KineticID is 510(k)-pending software for dynamic PET imaging and kinetic modeling, enabling time-based radiotracer analysis for clinical and research decisions (Photo courtesy of GE Healthcare)

GE HealthCare Showcases AI-Enabled Nuclear Medicine Portfolio at SNMMI 2026

Nuclear medicine is expanding rapidly as health systems adopt theranostics and broaden access to radiopharmaceuticals, increasing demand for scalable operations and consistent diagnostic confidence.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.